Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
0.92x
NEULANDLAB's operating cash flow covered 92% of net income in FY 2025. Some earnings may be tied up in working capital.
Free Cash Flow
₹1.11B
NEULANDLAB's free cash flow was ₹1.11B in FY 2025, down 5.6% from FY 2024.
Dividend Coverage
6.2x
NEULANDLAB's free cash flow covered dividends 6.2x in FY 2025, leaving room for reinvestment or debt reduction.
CapEx Intensity
65.1%
Capital expenditure consumed 65.1% of operating cash flow in FY 2025 for NEULANDLAB, typical of capital-intensive industries.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 4.01B | 3.46B | |
| Cash flow Operating Activities | 2.61B | 3.17B | |
| Investments in PPE | -1.44B | -2.06B | |
| Cash flow Investing Activities | -1.50B | -2.98B | |
| Dividend Paid | -128.30M | -179.62M | |
| Cash flow Financing Activities | -692.82M | 249.61M | |
| Cash at beginning of period | 454.16M | 875.75M | |
| Cash at end of period | 875.75M | 1.32B | |
| Free Cash Flow | 1.18B | 1.11B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025